Autonomic "myasthenia": The case for an autoimmune pathogenesis

Journal of Clinical Investigation

Volumn 111, Issue 6, 2003, Pages 797-799

  Drachman, Daniel B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; NICOTINIC RECEPTOR;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; IMMUNIZATION; MYASTHENIA; NEUROMUSCULAR SYNAPSE; NOTE; PASSIVE TRANSPORT; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; AUTONOMIC NEUROPATHY; BLOOD; HUMAN; IMMUNOLOGY; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; RABBIT;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; HUMANS; IMMUNIZATION; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RABBITS; RECEPTORS, NICOTINIC;

EID: 85047687824     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18180     Document Type: Note

References (17)

1. Drachman, D.B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797-1810.
2. Lennon, V.A., Ermilov, L.G., Szurszewski, J.H., and Vernino, S. 2003. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest. 111:907-913. doi:10.1172/JCI200317429.
3. Suarez, G., Fealey, R., Camilleri, M., and Low, P. 1994. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 44:1675-1682.
4. Vernino, S., et al. 2000. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343:847-855.
5. Drachman, D.B. 1990. How to recognize an antibody-mediated autoimmune disease: criteria. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 68:183-186.
6. Vernino, S., Adamski, J., Kryzer, T.J., Fealey, R.D., and Lennon, V.A. 1998. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 50:1806-1813.
7. Brooks, E.B., Pachner, A.R., Drachman, D.B., and Kantor, F.S. 1990. A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis. J. Neuroimmunol. 28:83-93.
8. Drachman, D.B., de Silva, S., Ramsay, D., and Pestronk, A. 1987. Humoral pathogenesis of myasthenia gravis. Ann. NY Acad. Sci. 505:90-105.
9. Drachman, D., DeSilva, S., Ramsay, D., and Pestronk, A. 1987. "Sero-negative" myasthenia gravis: a humorally mediated variant of myasthenia. Neurology. 37(Suppl. 1):214.
10. Burges, J., et al. 1994. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve. 17:1393-1400.
11. Hoch, W., et al. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7:365-368.
12. Darnell, R.B. 1996. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc. Natl. Acad. Sci. U. S. A. 93:4529-4236.
13. Schoepfer, R., Halvorsen, S.W., Conroy, W.G., Whiting, P., and Lindstrom, J. 1989. Antisera against an acetylcholine receptor alpha 3 fusion protein bind to ganglionic but not to brain nicotinic acetylholine receptors. FEBS Lett. 257:393-399.
14. Xu, W., et al. 1999. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 96:5746-5751.
15. Toyka, K.V., Drachman, D.B., Pestronk, A., and Kao, I. 1975. Myasthenia gravis: passive transfer from man to mouse. Science. 190:397-399.
16. Rose, N., and Mackay, I. 1998. The autoimmune diseases: prelude. In The autoimmune diseases. N. Rose and I. Mackay, editors. Academic Press. San Diego, California, USA. 1.
17. Drachman, D.B., et al. 2003. Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy. Ann. N. Y. Acad. Sci. In press.